This year is a dynamic and fast-paced one for compounding pharmacy M&A. Early in the year, unpredictability in the broader[...]
More
LTC Pharmacy underwent more disruption and change in just the past few years than the preceding decades. Revenue models morphed,[...]
More
The healthcare services sector continues to attract attention from buyers across a broad range of backgrounds. While late 2021 and[...]
More
What’s driving the interest in compounding pharmacy? Disruption, growth and industry architecture. First, acquirers are aggressively seeking to establish boots[...]
More
If you are reading this, you’re likely seeking an answer to the popular question: “How has the pandemic impacted the[...]
More
For much of the last decade, compounding pharmacies encountered headwinds in the M&A markets. A combination of high government scrutiny,[...]
More
Long-term care pharmacy faced unprecedented disruptions during 2020. Patients across the entire continuum of care felt an impact in some[...]
MoreSpecialty pharmacy is the fastest growing pharmacy segment and it is estimated that specialty drugs accounted for nearly 70% of[...]
More
The last 20 years delivered ups and downs to long-term care (LTC) pharmacies that caused significant disruption in the M&A[...]
More
There is another exciting year ahead for the long-term care (LTC) pharmacy M&A market. Before we look into the crystal[...]
More
